Simplify Logo

Full-Time

Histotechnologist II

Posted on 7/15/2024

Tempus

Tempus

1,001-5,000 employees

AI-driven healthcare data analysis platform

Data & Analytics
Hardware
AI & Machine Learning
Financial Services
Biotechnology
Healthcare

Entry

Durham, NC, USA

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Communications
Requirements
  • HT or HTL Certification preferred
  • Associates or Bachelor's Degree
  • Familiarity with Leica equipment, manual microtomes, both Leica and Roche automated IHC staining instruments
  • Knowledge of CAP regulations
  • Experience with pathology laboratory SOPs and protocols
  • Comfort with laboratory safety and training
  • Demonstrates problem-solving skills in the laboratory
  • Good communication and organization skills
Responsibilities
  • Preparation of unstained and routine hematoxylin and eosin stained slides
  • Maintaining laboratory equipment and recording maintenance
  • Performing routine workflows without specific guidance
  • Assisting in the development of standard operating procedures
  • Collaborating with other team members
  • Utilizing various laboratory equipment
  • Collaborating with in-house pathologists for slide quality review
  • Cutting frozen sections using a cryostat
  • Tracking work completed using a custom Laboratory Information Management System
  • Working collaboratively with the Histology team to meet deadlines

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in the healthcare sector. The company offers a platform that analyzes medical data, helping physicians make better treatment decisions by providing insights from medical images and identifying care gaps. For pharmaceutical and biotech companies, Tempus aids in drug development by discovering new targets and assessing treatment effectiveness. Patients benefit from personalized therapy options identified through the platform. Tempus conducts significant research, particularly in cancer, and has developed tools like a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. The company generates revenue by charging healthcare providers and companies for access to its platform and insights.

Company Stage

Series G

Total Funding

$1.3B

Headquarters

Chicago, Illinois

Founded

2015

Growth & Insights
Headcount

6 month growth

5%

1 year growth

12%

2 year growth

36%
Simplify Jobs

Simplify's Take

What believers are saying

  • Tempus's IPO and significant revenue generation indicate strong financial health and growth potential.
  • Collaborations with industry giants like SoftBank and United Therapeutics can lead to groundbreaking advancements and increased market share.
  • The company's focus on personalized therapy and AI-driven insights can significantly improve patient outcomes, making it a rewarding place to work for those passionate about healthcare innovation.

What critics are saying

  • The lawsuit from Guardant Health over patent infringement could result in financial and reputational damage.
  • Operating in a highly competitive market with peers like Foundation Medicine and Guardant Health requires continuous innovation to maintain a competitive edge.

What makes Tempus unique

  • Tempus leverages AI to provide actionable insights from medical data, setting it apart from competitors who may not integrate AI as deeply into their platforms.
  • Their focus on personalized therapy options and extensive cancer research, including a pan-cancer organoid platform and liquid biopsy assay, distinguishes them in the healthcare tech space.
  • Tempus's collaboration with major firms like SoftBank and United Therapeutics highlights its strong industry partnerships and credibility.
INACTIVE